Content area

|
|

Succesfuld behandling af akut promyelocytleukæmi uden brug af kemoterapi og blodtransfusion

Forfattere
Michael Tøstesen, Lene S.G. Østgård, Eigil Kjeldsen, Jesper Stentoft & Jan M. Nørgaard Hæmatologisk Afdeling, Aarhus Universitetshospital Ugeskr Læger 2018;180:V06170489
Reference: 
Ugeskr Læger 2018;180:V06170489
Blad nummer: 
Sidetal: 
2-3
Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion
Untreated acute promyelocytic leukaemia (APL) is a rapidly lethal blood cancer. Conventional treatment consists of all-trans retinoic acid and chemotherapy. Standard chemo­therapy-containing treatments necessitate the use of blood products. This is a case report of typical APL in a 32-year-old female patient, who due to religious conviction refused supportive therapy with blood products. A treatment regimen consisting of all-trans retinoic acid and arsenic trioxide was successful without the use of blood transfusions.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Connie Lærkholm Hansen | 17/07
33 kommentarer
af Bente Lützen | 16/07
1 Kommentar
af Christian Frøkjær Thomsen | 16/07
1 Kommentar
af Klaus Roelsgaard | 15/07
2 kommentarer
af Geske Johanne Glahn | 14/07
1 Kommentar
af Finn Redke | 14/07
4 kommentarer
af Finn Redke | 14/07
3 kommentarer